Quote:
Originally Posted by CorsiHockeyLeague
The top 5 drug manufacturers, also known as "the people who are curing cancer". How much of that $50 bn went back into R&D?
|
None. R&D costs are normally considered operational costs and can be written off for tax credit, increasing the bottom line. For pharma, profit is the cream off the top.
https://www.statista.com/statistics/...on-net-income/
http://www.pharmexec.com/2016-pharm-exec-50
http://www.bbc.com/news/business-28212223
Looking at just the US operations in 2015, Pfizer ($43.112B), Kerck ($35.244B), Gilead ($32.151B), Johnson & Johnson ($29.864B), and Glaxo (S27.051B) had combined revenues of $167.422B. These companies spent 17% ($28.861B) on R&D costs. Almost all of them spent two times that (or more) on advertising.
Pfizer alone made a whopping 42% profit on $43.112B in revenues. That's a staggering $18.1B in profit, or 236% of R&D expenditures.
Quote:
|
Bernie's mob-stoking class warfare populist rhetoric isn't much better than Trump's at times.
|
Your inability to do research and find out your rhetoric is weak is almost as bad as Texas Flames Fans.
